According to IMARC Group’s latest report, titled “Bromelain Market Size: Industry Trends, Share, Growth, Opportunity and Forecast 2021-2026,” the global bromelain market grew at a CAGR of around 5% during 2015-2020. Looking forward, the market is expected to exhibit moderate growth during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Bromelain is a protein-digesting enzyme obtained from the stem and fruit of the pineapple plant. It is an inhibitor of blood platelet aggregation, which reduces the risk of arterial thrombosis and consequently works as an effective agent in treating cardiovascular diseases (CVDs). It also finds extensive application in homeopathy as an alternative treatment to nonsteroidal anti-inflammatory drugs (NSAIDs) is impacting the market favorably. Besides this, topical bromelain ointments are considered beneficial for burns debridement.
Request Free Sample Report: https://www.imarcgroup.com/bromelain-market/requestsample
The extensive applications of bromelain in the healthcare and pharmaceutical industries worldwide is primarily driving the market, as it is utilized as a dietary supplement for reducing pain, swelling, and bruising after surgery. Moreover, the growing demand for bromelain to treat CVDs, chronic inflammation, malignant and autoimmune diseases is further propelling the product demand. Additionally, bromelain is gaining traction in the oral enzyme therapies for oncology patients as it can be absorbed in the intestines without even affecting biological activity, which in turn is providing a positive outlook to the market. Besides this, increasing usage of bromelain as a meat tenderizer in the food and beverage industry is projected to further catalyze the market growth in the coming years.
Ask Analyst and Browse Full Report with TOC & List of Figure: https://bit.ly/3fLiRNS
List of Key Companies Covered in this Market Report:
- Advanced Enzyme Technologies Limited (NSE: ADVENZYMES)
- Bio-gen Extracts Private Limited.
- Changsha Natureway Co. Ltd.
- Creative Enzymes
- Enzybel International (Floridienne S.A.)
- Enzyme Development Corporation
- Enzyme Technologies (PTY) Ltd.
- Guangxi Nanning Javely Biological Products Co. Ltd.
- Hong Mao Biochemicals Co. Ltd.
- Mitushi Biopharma
- Xena Bio Herbals Pvt. Ltd.
The report has segmented the market on the basis of source, application and geography.
Breakup by Source:
Breakup by Application:
- Food and Beverages
Breakup by Geography:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021- 2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: [email protected]
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800